Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 mg | 0 left in stock | $1,050.00 |
About This Item
Empirical Formula (Hill Notation):
C10H13N3O · 0.5H2SO4
CAS Number:
Molecular Weight:
240.27
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12161501
MDL number:
Form:
solid
Quality level:
form
solid
Quality Level
color
off-white
mp
267 °C
storage temp.
2-8°C
SMILES string
OS(O)(=O)=O.NC(=N)N1CC(O)c2ccccc2C1.NC(=N)N3CC(O)c4ccccc4C3
InChI
1S/2C10H13N3O.H2O4S/c2*11-10(12)13-5-7-3-1-2-4-8(7)9(14)6-13;1-5(2,3)4/h2*1-4,9,14H,5-6H2,(H3,11,12);(H2,1,2,3,4)
InChI key
AETJLQVZNVTWPH-UHFFFAOYSA-N
Application
(±)-4-Hydroxydebrisoquin sulfate can be used for the metabolic studies of debrisoquin.
Biochem/physiol Actions
CYP2D6 metabolite of debrisoquin.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
1 of 1
This Item | |||
|---|---|---|---|
| form solid | form crystalline | form solid | form powder |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. −20°C | storage temp. 2-8°C | storage temp. 2-8°C |
| color off-white | color yellow | color white to off-white | color light yellow to dark orange |
| mp 267 °C | mp - | mp - | mp - |
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M Lanz et al.
Electrophoresis, 18(10), 1875-1881 (1998-02-12)
Using capillary zone electrophoresis with a phosphate buffer at pH 2.5 containing 50 mM heptakis-(2,3,6-tri-O-methyl)-beta-CD as chiral selector, the separation of the enantiomers of the main metabolite of debrisoquine (DEB), 4-hydroxydebrisoquine (4-OHDEB), is reported. For extraction of underivatized urinary DEB
O O Simooya et al.
British journal of clinical pharmacology, 45(3), 315-317 (2000-07-15)
To determine the effect of therapeutic loading doses of halofantrine and chloroquine on CYP2D6 activity in healthy black Zambians. Twenty healthy black male Zambians were phenotyped for CYP2D6 activity by measuring the debrisoquine/4-hydroxydebrisoquine ratio in a 0-8 h urine sample
G L Shaw et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 4(1), 41-48 (1995-01-01)
Previous reports of the association between the debrisoquine metabolic polymorphism and lung cancer risk have been conflicting. We examined the hypothesis that the genetically determined ability to metabolize debrisoquine identifies individuals at increased risk for lung cancer in a study
Global Trade Item Number
| SKU | GTIN |
|---|---|
| UC261-10MG | 04061832932064 |
| UC261-5MG | 04061832932071 |




